Successful treatment of intrathecal methotrexate overdose by using ventriculolumbar perfusion and intrathecal instillation of carboxypeptidase G2

Mayo Clinic Proceedings

Volumn 71, Issue 2, 1996, Pages 161-165

  O'Marcaigh, Aengus S ^a   Johnson, Christopher M ^b   Smithson, William A ^c   Patterson, M C ^e   Widemann, Brigitte C ^d   Adamson, Peter C ^c   Mcmanus, Michael J ^a  

^a Section of Pédiatrie Hematology Oncology   (United States)

^b and Sleep Medicine   (United States)

^c MAYO CLINIC ROCHESTER   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYPEPTIDASE G2; METHOTREXATE; PREDNISONE; SODIUM CHLORIDE; VINCRISTINE SULFATE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BRAIN PERFUSION; BRAIN VENTRICLE; CASE REPORT; CEREBROSPINAL FLUID DRAINAGE; CHILD; DRUG CEREBROSPINAL FLUID LEVEL; DRUG OVERDOSE; HUMAN; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LUMBAR PUNCTURE; MALE; NEUROTOXICITY; ORAL DRUG ADMINISTRATION;

EID: 0030060048     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/71.2.161     Document Type: Article

References (13)

1. Allegra CJ. Antifolates. In: Chabner BA, Collins JM, editors. Cancer Chemotherapy: Principles and Practice. Philadelphia: Lippincott, 1990: 110-153
2. Luddy RE, Oilman PA. Paraplegia following intrathecal methotrexate. J Pediatr 1973; 83:988-992
3. Lampkin BC, Higgins GR, Hammond D. Absence of neurotoxicity following massive intrathecal administration of methotrexate: case report. Cancer 1967; 20:17801781
4. Ettinger LJ, Freeman AI, Creaven PJ. Intrathecal methotrexate overdose without neurotoxicity: case report and literature review. Cancer 1978; 41:1270-1273
5. Addiego JE Jr, Ridgway D, Bleyer WA. The acute management of intrathecal methotrexate overdose: pharmacologie rationale and guidelines. J Pediatr 1981; 98:825-828
6. Jakobson AM, Kreuger A, Mortimer O, Henningsson S, Seidel H, Moe PJ. Cerebrospinal fluid exchange after intrathecal methotrexate overdose: a report of two cases. ActaPaediatr 1992; 81:359-361
7. Ettinger LJ. Pharmacokinetics and biochemical effects of a fatal intrathecal methotrexate overdose. Cancer 1982; 50:444-450
8. Spiegel RJ, Cooper PR, Blum RH, Speyer JL, McBride D, Mangiardi J. Treatment of massive intrathecal methotrexate overdose by ventriculolumbar perfusion. N Engl J Med 1984; 311:386-388
9. Adamson PC, Balis FM, McCully CL, Godwin KS, Bacher JD, Walsh TJ, et al. Rescue of experimental intrathecal methotrexate overdose with carboxypeptidase-G2. J Clin Oncol 1991; 9:670-674
10. Widemann BC, Hetherington ML, Murphy RF, Balis FM, Adamson PC. Carboxypeptidase-G2 rescue in a patient with high dose methotrexate-induced nephrotoxicity. Cancer 1995; 76:521-526
11. Shapiro WR, Young DF, Mehta BM. Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections. N Engl J Med 1975; 293:161-166
12. Bode U, Magrath IT, Bleyer WA, Poplack DG, Glaubiger DL. Active transport of methotrexate from cerebrospinal fluid in humans. Cancer Res 1980; 40:2184-2187
13. Laborit H-M. Theroleof folic acid in central nervous system physiology. In: Botez MI, Reynolds EH, editors. Folic Acid in Neurology, Psychiatry, and Internal Medicine. New York: Raven Press, 1979:249-266